Expression of cyclooxygenase-1 and-2 in human breast cancer

被引:35
作者
Yoshimura, N
Sano, H
Okamoto, M
Akioka, K
Ushigome, H
Kadotani, Y
Yoshimura, R
Nobori, S
Higuchi, A
Ohmori, Y
Nakamura, K
机构
[1] Kyoto Prefectural Univ Med, Dept Organ Transplant & Endocrinol Surg, Kamigyo Ku, Kyoto 6020841, Japan
[2] Kyoto Prefectural Univ Med, Dept Internal Med 1, Kamigyo Ku, Kyoto 6020841, Japan
[3] Osaka City Univ, Fac Med, Dept Urol, Osaka 558, Japan
关键词
cyclooxygenase-1; cyclooxygenase-2; breast cancer; mastopathy; fibroadenoma;
D O I
10.1007/s00595-003-2606-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose. We investigated the expression of cyclooxygenase (Cox-1 and Cox-2) in mammary tissues from patients with breast cancer. Methods. We used reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry. Results. The cancer cells showed very weak expression of Cox-1, but strong expression of immunoreactive Cox-2. In contrast, immunoreactive Cox-2 was very weak in all of the benign mammary tumors examined, including fibroadenoma (FA) and mastopathy (MP). Immunoreactive Cox-1 was also very weak in these benign tumors. The extent and intensity of immunoreactive Cox-2 polypeptides was significantly greater in the cancer cells than in the FA cells or MP cells. RT-PCR analysis showed enhanced expression of Cox-2, but not Cox-1 in breast cancer tissue, and faint expression of Cox-2 in benign tissue. Conclusions. These results demonstrated that human breast cancer cells generated Cox-2, indicating that Cox-2 might play an important role in the proliferation of breast cancer cells.
引用
收藏
页码:805 / 811
页数:7
相关论文
共 52 条
  • [31] POLYCYCLIC AROMATIC HYDROCARBON OXIDATION DURING PROSTAGLANDIN BIOSYNTHESIS
    MARNETT, LJ
    [J]. LIFE SCIENCES, 1981, 29 (06) : 531 - 546
  • [32] CDNA CLONING AND FUNCTIONAL-ACTIVITY OF A GLUCOCORTICOID-REGULATED INFLAMMATORY CYCLOOXYGENASE
    OBANION, MK
    WINN, VD
    YOUNG, DA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) : 4888 - 4892
  • [33] REMINGTON RD, 1985, STAT APPL BIOL HLTH, P415
  • [34] Ristimaki A, 1997, CANCER RES, V57, P1276
  • [35] ROLLAND PH, 1981, J GYNECOL OBST BIO R, V10, P295
  • [36] ROLLAND PH, 1980, JNCI-J NATL CANCER I, V64, P1061
  • [37] COEXPRESSION OF PHOSPHOTYROSINE-CONTAINING PROTEINS, PLATELET-DERIVED GROWTH FACTOR-B, AND FIBROBLAST GROWTH FACTOR-I INSITU IN SYNOVIAL TISSUES OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND LEWIS RATS WITH ADJUVANT OR STREPTOCOCCAL CELL-WALL ARTHRITIS
    SANO, H
    ENGLEKA, K
    MATHERN, P
    HLA, T
    CROFFORD, LJ
    REMMERS, EF
    JELSEMA, CL
    GOLDMUNTZ, E
    MACIAG, T
    WILDER, RL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (02) : 553 - 565
  • [38] SANO H, 1995, CANCER RES, V55, P3785
  • [39] INVIVO CYCLOOXYGENASE EXPRESSION IN SYNOVIAL TISSUES OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND OSTEOARTHRITIS AND RATS WITH ADJUVANT AND STREPTOCOCCAL CELL-WALL ARTHRITIS
    SANO, H
    HLA, T
    MAIER, JAM
    CROFFORD, LJ
    CASE, JP
    MACIAG, T
    WILDER, RL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) : 97 - 108
  • [40] SIMMONS DL, 1991, PROSTAGLANDIN LEUKOT, P57